Elevance Health (NYSE:ELV) Shares Rise as Q3 Earnings Beat and Raised Outlook Offset Inline Revenue
Elevance Health (ELV) Q3 2026 EPS beat consensus while revenue stayed inline; raised 2026 outlook and strong profitability lifted shares premarket.
What This Story Means
Claude is explaining the story in plain words…
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: ChartMill